Per Svenningsson is a neurologist specializing in the neuropharmacology of movement disorders such as Parkinson’s disease.
Education
Svenningsson received his Doctor of Medicine and Doctor of Philosophy from the Karolinska Institutet in Stockholm, Sweden, where he also completed postdoctoral research. In 2012 he was appointed full professor in the Department of Clinical Neuroscience and the Department of Neurology at the Karolinska University Hospital.
Career
He is a professor of neurology at the Department of Clinical Neuroscience at the Karolinska Institutet and in the Department of Neurology at Karolinska University Hospital in Stockholm, Sweden. He is the team leader of a research group that studies the underlying pathogenic process of Privatdozent . Education Research focus/interests Svenningsson is the team leader of a research group that studies movement disorders such as Parkinson’s disease at the molecular and cellular level The focus of the group is to uncover non-motor symptoms of Privatdozent that manifest early on in the disease with the hopes of creating neuroprotective drugs to combat its progression.
Positions of trust and research assessments In addition to research and teaching, Svenningsson holds a number of positions of trust.
He was a former grant reviewer for Institut national de la santé et de la recherche médicale/French National Research Agency in France. He has been on the reviewing committee of the Finnish Medical Research Council, the Swedish Parkinson Fund, and the Norwegian Medical Research Council.
Membership
Svenningsson is also a member of many research councils and committee, including the European College of Neuropsychopharmacology (ECNP). He is a member of the Ulf von Euler Lecturer committee and a councilor on the Executive Committee of the European College of Neuropsychopharmacology (ECNP).